Delivery Order SPE2DR25D1109-SPE2DR26FFH0C
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,837.63 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on December 12, 2025, with completion scheduled for December 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. Trulicity is a diabetes management medication commonly used by military and veteran healthcare systems...
- The Defense Logistics Agency awarded a delivery order valued at $4,155.60 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL) with an ultimate completion date of April 23, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an existing contract vehicle. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Trulicity is a brand-name diabetes medication commonly...
- The Defense Logistics Agency awarded a delivery order valued at $10,343.94 to AmerisourceBergen Drug Corp for the supply of Trulicity 3 mg/0.5 ml pens on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a brand-name diabetes medication widely used in federal healthcare systems, including...
- The Defense Logistics Agency awarded a delivery order valued at $4,524.12 to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on April 24, 2025, with an ultimate completion date of April 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, executed under competitive procedures. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used in federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,948.99 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on November 6, 2025, with completion scheduled for November 7, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication widely used in military and veteran healthcare...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,121.79 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 ml pens on July 15, 2025. This firm fixed-price delivery order, designated as a non-competitive award under the company's existing indefinite delivery contract with DLA, is scheduled for completion by July 16, 2025, with performance occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication...
- The Defense Logistics Agency awarded a $3,823.68 delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Trulicity 4.5 mg/0.5 mL pens with a completion date of November 4, 2025. This is a firm fixed-price, non-competitive delivery order with no set-aside designation, to be performed at the vendor's Conshohocken, Pennsylvania location. Trulicity is a diabetes medication commonly used within military and federal healthcare systems to support chronic disease...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,351.35 on September 19, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by September 22, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used within military and veteran healthcare systems supported...
- The Defense Logistics Agency awarded a delivery order valued at $5,814.80 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 ml pens on November 3, 2025, with an ultimate completion date of November 4, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used within military and veteran healthcare systems supported...
- The Defense Logistics Agency awarded a delivery order valued at $3,527.97 to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on August 26, 2025, with an ultimate completion date of August 27, 2025. This non-set-aside, firm fixed price delivery order was competitively awarded and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trulicity is a diabetes medication commonly used in military and veteran healthcare systems as part of comprehensive...
- SPE2DR25D1109Indefinite Delivery Contract
- SPE2DR25D1109-SPE2DR26FFH0CDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,566.21 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens on November 25, 2025. This is a firm fixed-price delivery order with an ultimate completion date of November 26, 2025, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation. Trulicity is a brand-name diabetes medication commonly used in military and veteran healthcare systems supported through DLA's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen maintains an extensive portfolio of delivery orders through DLA covering numerous therapeutic domains and product categories across multiple customer bases, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 11/24/25 |